Sort
39,280 grants matching “leukemia”
Blockade of IL-23 for the Prevention of Graft Versus Host Disease
$566,431William R. Drobyski · Medical College Of Wisconsin · R01 · FY2023 · HL
Immunobiology of Normal and Neoplastic Lymphocytes
$566,422Warren S Pear · University Of Pennsylvania · T32 · FY2021 · CA
Strategies for Therapeutic Cancer Vaccine Clinical Trials
$566,341Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
$566,313Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2022 · CA
Clinical Trials Exploiting NK Cell Activity
$566,011Daniel J Weisdorf · University Of Minnesota · P01 · FY2020 · CA
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
$565,864Lisa Rimsza · University Of Arizona · U01 · FY2014 · CA
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$565,815Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
$565,763Areej El-Jawahri · Massachusetts General Hospital · R01 · FY2025 · CA
The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppression
$565,675Shan Zha · Columbia University Health Sciences · R01 · FY2023 · CA
"Off-the-Shelf" iPSC-Derived Regulatory T Cell Immunotherapeutics
$565,672Bruce R. Blazar · University Of Minnesota · P01 · FY2024 · CA
ITIM-receptors for cancer treatment
$565,597Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
$565,491James Versalovic · Baylor College Of Medicine · U01 · FY2016 · CA
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$565,455Robert G Roeder · Rockefeller University · R01 · FY2015 · CA
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$565,455Robert G Roeder · Rockefeller University · R01 · FY2016 · CA
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
$565,455Robert G Roeder · Rockefeller University · R01 · FY2017 · CA
Genotyping for epidemiology studies
$565,346Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA
Defining the partner interaction network of the tetraspanin CD53 in regulating B cell trafficking
$565,339Laura G. Schuettpelz · Washington University · R01 · FY2023 · AI
Alcohol and AIDS: Pathogenesis and Immunity in Macaque
$565,273Anil Kumar · University Of Missouri Kansas City · R01 · FY2007 · AA
PolQ as a novel therapeutic target in AML
$565,257Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2020 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$565,188Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Defining the scope and clinical impact of donor CHIP after allogeneic HCT
$565,186Robert Coleman Lindsley · Dana-Farber Cancer Inst · P01 · FY2022 · CA
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$565,118Shan Zha · Columbia University Health Sciences · R01 · FY2024 · CA
Therapeutic implication of CD38 in CLL
$565,086Eduardo N Chini · Mayo Clinic Jacksonville · R01 · FY2023 · CA
The function and underlying mechanism of TET1 in myelodysplastic syndromes
$564,921Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2020 · DK
Transcriptional regulatory landscapes underlying FEZ Formation
$564,900Ralph S Marcucio · University Of California, San Francisco · R01 · FY2021 · DE